# Tolerability of Utidelone Capsule in Patients With Advanced Solid Tumors

> **NCT05681000** · PHASE1 · UNKNOWN · sponsor: **Biostar Pharma, Inc.** · enrollment: 28 (estimated)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** Utidelone Capsule

## Key facts

- **NCT ID:** NCT05681000
- **Lead sponsor:** Biostar Pharma, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06-09
- **Primary completion:** 2024-04-15
- **Final completion:** 2024-12-31
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2023-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05681000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05681000, "Tolerability of Utidelone Capsule in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05681000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*